Results 31 - 40 of 299 : Previous 1 2 3 4 5 6 7 8 9 Next
Cost-cutting and revenue growth make WuXi a looker for the year.
Stick with these winners even after you quit.
Unfortunately, it won't last.
Finally! It's a Win, Isn't It?
The FDA is doing more than just pulling drugs off the market.
A Big Upgrade for Abbott Laboratories
This bullish call comes from more than just one analyst.
Sorry, no alcohol involved.
Looking for a Sliver of the Me-Too Pie
Another diabetes drug is close to hitting the market.
No more pay for delay?
Is the FDA cracking down?
Buying great stocks can be painful.